BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 10/06/2016

FDA Releases Guidance on Compounding with Bulk Drug Substances

The FDA has announced a new guidance for industry regarding compounding with bulk drug substances, outlining the agency's interim policy on outsourcing facilities that compound human drug products using bulk drug substances while the FDA develops its list of approved substances.

Source: Federal Register — Food and Drug AdministrationOpen original release →